Naphthylurea derivatives and medical applications thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 2016
Issued Date -
N/A
app pub date -
Aug 20, 2014
filing date -
Sep 29, 2013
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to naphthylurea derivatives. Such substances can significantly inhibit VEGFR2 and PDGFR-β receptor tyrosine kinase phosphorylation at nanomolar concentration levels. It is a novel type of tyrosine kinase inhibitors which can be used in the treatment of tyrosine kinase-mediated diseases or symptoms such as malignancies and ocular diseases accompanied with pathologic neovascularization.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully